An update from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) is now available.
WuXi AppTec Co., Ltd. announced its annual results for the year ended December 31, 2024, reporting a slight decline in revenue and net profit compared to the previous year. Despite the decrease in financial performance, the company has proposed a final dividend and a special dividend distribution to appreciate shareholder support during strategic adjustments in challenging times, subject to shareholder approval at the forthcoming AGM.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. The company provides a range of services including research, development, and manufacturing support to pharmaceutical, biotech, and medical device companies globally.
YTD Price Performance: 14.16%
Average Trading Volume: 5,403,051
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$194.8B
See more insights into 2359 stock on TipRanks’ Stock Analysis page.